MedImmune LLC
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Established
- 1987-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://medimmune.com
Study of the Efficacy and Safety of MEDI4893
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2019-12-23
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 213
- Registration Number
- NCT02296320
- Locations
- ๐จ๐ญ
Research Site, Lausanne, Switzerland
A Phase 1b/2a Randomized, Double-Blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-11-14
- Last Posted Date
- 2018-09-19
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 151
- Registration Number
- NCT02290340
- Locations
- ๐ฟ๐ฆ
Research Site, Pretoria, South Africa
A Study to Evaluate the Safety and Immunogenicity of MEDI7510 in Older Adults
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-11-13
- Last Posted Date
- 2018-03-15
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 363
- Registration Number
- NCT02289820
- Locations
- ๐บ๐ธ
Research Site, Nashville, Tennessee, United States
Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis
- First Posted Date
- 2014-10-29
- Last Posted Date
- 2016-11-21
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 29
- Registration Number
- NCT02277574
- Locations
- ๐บ๐ธ
Physician Research Collaboration, LLC, Lincoln, Nebraska, United States
๐บ๐ธMetroplex Clinical Research Center, Dallas, Texas, United States
๐บ๐ธPinnacle Research Group, LLC, Anniston, Alabama, United States
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-10-22
- Last Posted Date
- 2018-03-12
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 10
- Registration Number
- NCT02271945
- Locations
- ๐บ๐ธ
Research Site, Milwaukee, Wisconsin, United States
A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab in Head and Neck Cancer
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-10-13
- Last Posted Date
- 2017-10-23
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 71
- Registration Number
- NCT02262741
- Locations
- ๐จ๐ฆ
Research Site, Toronto, Ontario, Canada
A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-10-10
- Last Posted Date
- 2020-03-06
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 380
- Registration Number
- NCT02261220
- Locations
- ๐ฌ๐ง
Research Site, Wirral, United Kingdom
Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-10-03
- Last Posted Date
- 2018-08-13
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 56
- Registration Number
- NCT02255760
- Locations
- ๐บ๐ธ
Research Site, South Miami, Florida, United States
Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
- First Posted Date
- 2014-08-27
- Last Posted Date
- 2017-04-06
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 37
- Registration Number
- NCT02227108
- Locations
- ๐ฌ๐ง
Research Site, Bristol, United Kingdom
A Phase 1 Study to Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-08-21
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 39
- Registration Number
- NCT02221960
- Locations
- ๐ฆ๐บ
Research Site, Parkville, Australia
ยฉ Copyright 2024. All Rights Reserved by MedPath